Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12


Identification of naturally processed mumps virus epitopes by mass spectrometry: Confirmation of multiple CD8+ T cell responses in mumps patients.

de Wit J, Emmelot ME, Meiring H, van Gaans-van den Brink JAM, van Els CACM, Kaaijk P.

J Infect Dis. 2019 Sep 27. pii: jiz480. doi: 10.1093/infdis/jiz480. [Epub ahead of print]


The Human CD4+ T Cell Response against Mumps Virus Targets a Broadly Recognized Nucleoprotein Epitope.

de Wit J, Emmelot ME, Poelen MCM, Lanfermeijer J, Han WGH, van Els CACM, Kaaijk P.

J Virol. 2019 Mar 5;93(6). pii: e01883-18. doi: 10.1128/JVI.01883-18. Print 2019 Mar 15.


Mumps infection but not childhood vaccination induces persistent polyfunctional CD8+ T-cell memory.

de Wit J, Emmelot ME, Poelen MCM, van Binnendijk RS, van der Lee S, van Baarle D, Han WGH, van Els CACM, Kaaijk P.

J Allergy Clin Immunol. 2018 May;141(5):1908-1911.e12. doi: 10.1016/j.jaci.2017.11.047. Epub 2018 Jan 12. No abstract available.


Efficacy of host-dendritic cell vaccinations with or without minor histocompatibility antigen loading, combined with donor lymphocyte infusion in multiple myeloma patients.

Oostvogels R, Kneppers E, Minnema MC, Doorn RC, Franssen LE, Aarts T, Emmelot ME, Spierings E, Slaper-Cortenbach I, Westinga K, Goulmy E, Lokhorst HM, Mutis T.

Bone Marrow Transplant. 2017 Feb;52(2):228-237. doi: 10.1038/bmt.2016.250. Epub 2016 Nov 14.


Sepantronium bromide (YM155) improves daratumumab-mediated cellular lysis of multiple myeloma cells by abrogation of bone marrow stromal cell-induced resistance.

de Haart SJ, Holthof L, Noort WA, Minnema MC, Emmelot ME, Aarts-Riemens T, Doshi P, Sasser K, Yuan H, de Bruijn J, Martens AC, van de Donk NW, Lokhorst HM, Groen RW, Mutis T.

Haematologica. 2016 Aug;101(8):e339-42. doi: 10.3324/haematol.2015.139667. Epub 2016 May 5. No abstract available.


Development of an IFN╬│ ELISPOT for the analysis of the human T cell response against mumps virus.

Han WG, Emmelot ME, Jaadar H, Ten Hulscher HI, van Els CA, Kaaijk P.

J Immunol Methods. 2016 Apr;431:52-9. doi: 10.1016/j.jim.2016.02.010. Epub 2016 Feb 9.


The impact of circulating suppressor cells in multiple myeloma patients on clinical outcome of DLIs.

Franssen LE, van de Donk NW, Emmelot ME, Roeven MW, Schaap N, Dolstra H, Hobo W, Lokhorst HM, Mutis T.

Bone Marrow Transplant. 2015 Jun;50(6):822-8. doi: 10.1038/bmt.2015.48. Epub 2015 Mar 23.


Altered peptide ligands revisited: vaccine design through chemically modified HLA-A2-restricted T cell epitopes.

Hoppes R, Oostvogels R, Luimstra JJ, Wals K, Toebes M, Bies L, Ekkebus R, Rijal P, Celie PH, Huang JH, Emmelot ME, Spaapen RM, Lokhorst H, Schumacher TN, Mutis T, Rodenko B, Ovaa H.

J Immunol. 2014 Nov 15;193(10):4803-13. doi: 10.4049/jimmunol.1400800. Epub 2014 Oct 13.


Human regulatory T cells do not suppress the antitumor immunity in the bone marrow: a role for bone marrow stromal cells in neutralizing regulatory T cells.

Guichelaar T, Emmelot ME, Rozemuller H, Martini B, Groen RW, Storm G, Lokhorst HM, Martens AC, Mutis T.

Clin Cancer Res. 2013 Mar 15;19(6):1467-75. doi: 10.1158/1078-0432.CCR-12-2177. Epub 2013 Feb 4.


Forced overexpression of either of the two common human Foxp3 isoforms can induce regulatory T cells from CD4(+)CD25(-) cells.

Aarts-Riemens T, Emmelot ME, Verdonck LF, Mutis T.

Eur J Immunol. 2008 May;38(5):1381-90. doi: 10.1002/eji.200737590.


Human regulatory T cells control xenogeneic graft-versus-host disease induced by autologous T cells in RAG2-/-gammac-/- immunodeficient mice.

Mutis T, van Rijn RS, Simonetti ER, Aarts-Riemens T, Emmelot ME, van Bloois L, Martens A, Verdonck LF, Ebeling SB.

Clin Cancer Res. 2006 Sep 15;12(18):5520-5.

Supplemental Content

Loading ...
Support Center